Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence

Addiction Biology

Volumn 15, Issue 3, 2010, Pages 266-276

  Spiga, Saturnino ^a   Lintas, Alessandra ^b   Migliore, Michele ^c   Diana, Marco ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c CNR   (Italy)

Author keywords

Cannabinoids; Dopamine; Nucleus accumbens; THC; VTA; Withdrawal

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABIS; RIMONABANT; TETRAHYDROCANNABINOL; TYROSINE 3 MONOOXYGENASE; CANNABINOID; CANNABINOID 1 RECEPTOR; DOPAMINE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANNABIS ADDICTION; CELL DENSITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOARCHITECTURE; FUNCTIONAL ASSESSMENT; FUNCTIONAL MORPHOLOGY; GOLGI STAIN; HISTOLOGY; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MORPHOMETRICS; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SYNAPTOGENESIS; VENTRAL TEGMENTUM; WITHDRAWAL SYNDROME; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; LIMBIC SYSTEM; MESENCEPHALON; METABOLISM; NERVE CELL; NERVE CELL PLASTICITY; NERVE FIBER; NERVE TRACT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA; SYNAPSE; TOXICITY;

ANIMALS; AXONS; CANNABINOIDS; DOPAMINE; LIMBIC SYSTEM; MALE; MARIJUANA ABUSE; MESENCEPHALON; NEURAL PATHWAYS; NEUROGENESIS; NEURONAL PLASTICITY; NEURONS; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANTIA NIGRA; SYNAPSES; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 77953216492     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2010.00218.x     Document Type: Article

References (63)

1. 9-Tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. J Pharmacol Exp Ther 278 : 1290 1295.
2. Bass CE, Griffin G, Grier M, Mahadevan A, Razdan RK, Martin BR (2002) SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship study. Pharmacol Biochem Behav 74 : 31 40.
3. Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: hedonic impact, reward learning or incentive salience? Brain Res Rev 28 : 309 369.
4. Breivogel CS, Scates SM, Beletskaya IO, Lowery OB, Aceto MD, Martin BR (2003) The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors. Eur J Pharmacol 459 : 139 150.
5. Budney AJ, Hughes JR (2006) The cannabis withdrawal syndrome. Curr Opin Psychiatry 19 : 233 238. Review.
6. Chang HT (1952) Cortical neurons with particular reference to the apical dendrites. Cold Spring Harb Symp Quant Biol 17 : 189 202.
7. Cooper ZD, Haney M (2008) Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addict Biol 13 : 188 195.
8. Davis GW (2006) Homeostatic control of neural activity: from phenomenology to molecular design. Annu Rev Neurosci 29 : 307 323.
9. Di Chiara G (1999) Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol 375 : 13 30. Review.
10. Di Chiara G (2002) Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Eur J Pharmacol 137 : 75 114.
11. Diana M (1996) Dopaminergic neurotransmission and drug withdrawal: relevance to drug craving. In : Ohye VC, Kimura M, McKenzie J, eds. The Basal Ganglia Adv. Behav. Biol, pp. 123 130.
12. Diana M, Melis M, Muntoni AL, Gessa GL (1998) Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc Natl Acad Sci U S A 95 : 10269 71023.
13. Diana M, Muntoni AL, Pistis M, Melis M, Gessa GL (1999) Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur J Neurosci 11 : 1037 1041.
14. Diana M, Pistis M, Muntoni A, Gessa G (1995) Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J Pharmacol Exp Ther 72 : 781 785.
15. Diana M, Spiga S, Acquas E (2006) Persistent and reversible morphine withdrawal-induced morphological changes in the nucleus accumbens. Ann N Y Acad Sci 1074 : 446 457.
16. Diana M, Tepper JM (2002) Electrophysiological pharmacology of mesencephalic dopaminergic neurons. In : Di Chiara G, ed. Handbook of Experimental Pharmacology 154/II, pp. 1 62.
17. Galve-Roperh I, Aguado T, Palazuelos J, Guzmán M (2007) The endocannabinoid system and neurogenesis in health and disease. Neuroscientist 13 : 109 114.
18. Galve-Roperh I, Aguado T, Rueda D, Velasco G, Guzmán M (2006) Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development. Curr Pharm Des 12 : 2319 2325.
19. Gerdeman G, Lovinger DM (2001) CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol 85 : 468 471.
20. Glaser EM, Van der Loos H (1981) Analysis of thick brain sections by obverse-reverse computer microscopy: application of a new, high clarity Golgi-Nissl stain. J Neurosci Methods 4 : 117 125.
21. Gonzalez S, Fernandez-Ruiz J, Di Marzo V, Hernandez M, Arevalo C, Nicanor C, Cascio MG, Ambrosio E, Ramos JA (2004) Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol- tolerant rats: an experimental model of cannabinoid abstinence. Drug Alcohol Depend 74 : 159 170.
22. Gonzalez-Hernandez T, Rodriguez M (2000) Compartmental organization and chemical profile of dopaminergic and GABAergic neurons in the substantia nigra of the rat. J Comp Neurol 421 : 107 135.
23. Grace AA, Bunney BS (1983) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-2. Action potential generating mechanisms and morphological correlates. Neuroscience 10 : 317 331.
24. Gray EG (1959) Axo-somatic and axo-dendritic synapses of the cerebral cortex: an electron microscope study. J Anat 93 : 420 433.
25. Gruber AJ, O'Donnell P (2009) Bursting activation of prefrontal cortex drives sustained up states in nucleus accumbens spiny neurons in vivo. Synapse 63 : 173 180.
26. Haney M, Hart CL, Vosburg SK, Nasser J, Bennett A, Zubaran C, Foltin RW (2004) Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology 29 : 158 170.
27. Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW (1999) Abstinence symptoms following oral THC administration to humans. Psychopharmacology 141 : 395 404. (Pubitemid 29190008)
28. Hernández-Echeagaray E, Starling AJ, Cepeda C, Levine MS (2004) Modulation of AMPA currents by D2 dopamine receptors in striatal medium-sized spiny neurons: are dendrites necessary? Eur J Neurosci 19 : 2455 2463.
29. Hoffman AF, Oz M, Caulder T, Lupica CR (2003) Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. J Neurosci 23 : 4815 4820.
30. Iversen L (2003) Cannabis and the brain. Brain 126 : 1252 1270.
31. Kolb B, Gorny G, Limebeer CL, Parker LA (2006) Chronic treatment with delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats. Synapse 60 : 429 436.
32. Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278 : 52 58.
33. Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 : 97 129.
34. Mato S, Robbe D, Puente N, Grandes P, Manzoni OJ (2005) Presynaptic homeostatic plasticity rescues long-term depression after chronic delta 9-tetrahydrocannabinol exposure. J Neurosci 25 : 11619 11627.
35. Melis M, Pillolla G, Bisogno T, Minassi A, Petrosino S, Perra S, Muntoni AL, Lutz B, Gessa GL, Marsicano G, Di Marzo V, Pistis M (2006) Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiol Dis 24 : 15 27.
36. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL (2004) Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 24 : 53 62.
37. Melis M, Spiga S, Diana M (2005) The dopamine hypothesis of drug addiction: hypodopaminergic state. Int Rev Neurobiol 63 : 101 154.
38. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2 : 119 128.
39. Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278 : 58 63.
40. O'Donnell P, Grace AA (1993) Physiological and morphological properties of accumbens core and shell neurons recorded in vitro. Synapse 13 : 135 160.
41. Oades RD, Halliday GM (1987) Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res 434 : 117 165.
42. Paxinos G, Watson C (1998) The Rat Brain in Stereotaxic Coordinates, 3rd edn.
43. Pulvirenti L, Diana M (2001) Drug dependence as a disorder of neural plasticity: focus on dopamine and glutamate. Rev Neurosci 12 : 141 158.
44. Quickfall J, Crockford D (2006) Brain neuroimaging in cannabis use: a review. J Neuropsychiatry Clin Neurosci 18 : 318 332.
45. Rall W (1962) Electrophysiology of a dendritic neuron model. Biophys J 2 : 145 167.
46. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D et al 1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350 : 240 244.
47. Robinson TE, Berridge KC (2001) Incentive-sensitization and addiction. Addiction 96 : 103 114.
48. Robinson TE, Kolb B (1997) Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17 : 8491 8497.
49. Robinson TE, Kolb B (2004) Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47 (Suppl. 1 33 46.
50. Rubino T, Viganò D, Zagato E, Sala M, Parolaro D (2000) In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments. Synapse 35 : 8 14.
51. Shepherd GM (1994) Neurobiology, 3rd edn.
52. Sklair-Tavron L, Shi WX, Lane SB, Harris HW, Bunney BS, Nestler EJ (1996) Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci U S A 93 : 11202 11207.
53. Spiga S, Puddu MC, Pisano M, Diana M (2005) Morphine withdrawal-induced morphological changes in the nucleus accumbens. Eur J Neurosci 22 : 2332 2340.
54. Spiga S, Serra GP, Puddu MC, Foddai M, Diana M (2003) Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy. Eur J Neurosci 17 : 605 612.
55. Szabo B, Wallmichrath I, Mathonia P, Pfreundtner C (2000) Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata. Neuroscience 97 : 89 97.
56. 9-tetrahydrocannabinol. Eur J Pharmacol 376 : 23 26.
57. Tepper JM, Sawyer SF, Groves PM (1987) Electrophysiologically identified nigral dopaminergic neurons intracellularly labeled with HRP: light-microscopic analysis. J Neurosci 7 : 2794 2806.
58. Tredici G, Di Francesco A, Miani A, Pizzini G (1993) Real complete three-dimensional reconstruction of Golgi-impregnated neurons by means of a confocal laser scanning microscope. Neuroimage 1 : 87 93.
59. White FJ (1996) Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci 19 : 405 436.
60. Wilson CJ (1984) Passive cable properties of dendritic spines and spiny neurons. J Neurosci 4 : 281 297.
61. Wolf JA, Moyer JT, Lazarewicz MT, Contreras D, Benoit-Marand M, O'Donnell P, Finkel LH (2005) NMDA/AMPA ratio impacts state transitions and entrainment to oscillations in a computational model of the nucleus accumbens medium spiny projection neuron. J Neurosci 25 : 9080 9095.
62. Zito K, Knott G, Shepherd GM, Shenolikar S, Svoboda K (2004) Induction of spine growth and synapse formation by regulation of the spine actin cytoskeleton. Neuron 44 : 321 334.
63. Zito K, Svoboda K (2002) Activity-dependent synaptogenesis in the adult Mammalian cortex. Neuron 35 : 1015 1017. Review.